Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Julie Bjerre, Thygesen"'
Publikováno v:
EuroIntervention. 13:e1058-e1066
This study aimed to assess survival and causes of death in a real-world TAVR population as compared to an age- and sex-matched background population.Each aortic stenosis (AS) patient treated with TAVR in Eastern Denmark between 2007 and 2014 (n=617)
Autor:
Troels Højsgaard, Jørgensen, Julie Bjerre, Thygesen, Hans Gustav, Thyregod, Jesper Hastrup, Svendsen, Lars, Søndergaard
Publikováno v:
The Journal of invasive cardiology. 27(1)
Surgical aortic valve replacement (SAVR) and, more recently, transcatheter aortic valve implantation (TAVI) have been shown to be the only treatments that can improve the natural cause of severe aortic valve stenosis. However, after SAVR and TAVI, th
Autor:
Julie, Bjerre Thygesen, Poay Huan, Loh, Jiranut, Cholteesupachai, Olaf, Franzen, Lars, Søndergaard
Publikováno v:
The Journal of invasive cardiology. 26(2)
Conduction abnormalities (CA) requiring permanent pacemaker (PPM) are a well-known complication after transcatheter aortic valve implantation (TAVI). This study aimed to determine the incidence of TAVI-related PPM and reevaluate the indications for P
Publikováno v:
Journal of the American College of Cardiology. 68:B296
Several studies have described mortality in patients with severe aortic valve stenosis (AS) following transcatheter aortic valve replacement (TAVR) as compared to surgical aortic valve replacement (SAVR) or standard medical treatment. This study aime
Publikováno v:
Ugeskrift for laeger. 174(43)
In the late 1980's, Denmark was the birthplace for the concept of transcatheter valve implantation. In 2002, the first successful transcatheter aortic valve implantation (TAVI) was performed in humans. TAVI has matured beyond the learning-curve perio
Publikováno v:
Thygesen, J B, Glerup, H & Tarp, B 2012, ' Saccharomyces boulardii fungemia caused by treatment with a probioticum ', B M J Case Reports, vol. 2012 . https://doi.org/10.1136/bcr.06.2011.4412
Saccharomyces cerevisiae, known as baker's yeast, is normally considered a non-pathogenic yeast. A genetically very similar subtype, S boulardii, is used in a probioticum (Sacchaflor) to prevent antibiotic-associated diarrhoea and in the treatment of